Clinical and biological outcomes in an HIV-positive child treated with the immuno-modulator 6,6’-dithiodinicotinic acid (CPDS) over four years: A case report
Adolphe Ndarabu Igulu
Adolphe Ndarabu Igulu
Dept of Medicine, Centre Hospitalier Monkole, Kinshasa, Democratic Republic of the Congo.
Translational and Immuno-oncology, Infectious Disease and ImmunoEngineering Consulting, Guilford, CT, USA; Executive Consultant for the Grassetti Family Trust (GFT), Berkeley, CA, USA